Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 161
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Ebola video voice-over recording in 10 African local languages

Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Dicty World Race - finding the fastest and smartest Dicty cells

On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

Backer Badge Funded